IndraLab

Statements


| 3

reach
"Sulfasalazine (SSZ), an anti-inflammatory and immunosuppressive agent, inhibits IKKalpha and IKKbeta thereby blocking NFkB activation."

reach
"Sulfasalazine, a disease modifying anti-rheumatic drug (DMARD) launched for RA and other autoimmune disorders, was also reported to directly inhibit IKKalpha and IKKbeta by antagonizing ATP binding [XREF_BIBR]."

reach
"Sulfasalazine inhibited tumor necrosis factor alpha induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro."